0000000000543292

AUTHOR

Simona Dragan

showing 3 related works from this author

Dietary polyphenols for managing cancers: What have we ignored?

2020

Abstract Although the chemoprevention and anti-cancer activities of dietary polyphenols have been evidenced through both in vitro and in vivo studies, most of the human clinical trials were unsuccessful or even harmful. Debates on the beneficial roles of dietary polyphenols in cancer therapy are increasing. Many dietary polyphenols studies are conducted by in vitro experiments, but the nature of these studies does not consider the complexity of metabolic processes that are present in vivo. These can often cause instability in the dietary polyphenols, thereby leading to unsuccessful extrapolation into animal or human studies. Dietary polyphenols often have low bioavailability, which is mainl…

0301 basic medicineBioavailabilityCancer therapyMetabolitePharmacology03 medical and health sciences0302 clinical medicineAnti-cancer activityIn vivoMedicineTherapeutic windowCellular metabolismHuman studiesbusiness.industryMicrobiotafood and beveragesDietary polyphenolBioavailability030104 developmental biologyPolyphenol030220 oncology & carcinogenesisCancer cellbusinessStabilityFood ScienceBiotechnology
researchProduct

Effects of Coenzyme Q10 on Statin-Induced Myopathy

2015

Abstract Objective To evaluate the efficacy of coenzyme Q10 (CoQ10) supplementation on statin-induced myopathy. Participants and Methods We searched the MEDLINE, Cochrane Library, Scopus, and EMBASE databases (November 1, 1987, to May 1, 2014) to identify randomized controlled trials investigating the impact of CoQ10 on muscle pain and plasma creatine kinase (CK) activity as 2 measures of statin-induced myalgia. Two independent reviewers extracted data on study characteristics, methods, and outcomes. Results We included 6 studies with 302 patients receiving statin therapy: 5 studies with 226 participants evaluated the effect of CoQ10 supplementation on plasma CK activity, and 5 studies (4 u…

myalgiaCoenzyme Q10medicine.medical_specialtybiologybusiness.industryGeneral MedicineCochrane Librarylaw.inventionchemistry.chemical_compoundRandomized controlled trialchemistrylawStrictly standardized mean differenceInternal medicineMeta-analysisbiology.proteinPhysical therapyMedicineCreatine kinasemedicine.symptombusinessMyopathyMayo Clinic Proceedings
researchProduct

Dietary polyphenols as antidiabetic agents: Advances and opportunities

2020

Abstract Dietary polyphenols have been widely investigated as antidiabetic agents in cell, animals, human study, and clinical trial. The number of publication (Indexed by Web of Science) on “polyphenols and diabetes” significantly increased since 2010. This review highlights the advances and opportunities of dietary polyphenols as antidiabetic agents. Dietary polyphenols prevent and manage Type 2 diabetes mellitus via the insulin‐dependent approaches, for instance, protection of pancreatic islet β‐cell, reduction of β‐cell apoptosis, promotion of β‐cell proliferation, attenuation of oxidative stress, activation of insulin signaling, and stimulation of pancreas to secrete insulin, as well as…

bioavailability clinical study diabetes diabetic complication dietary polyphenols glucose absorption intestinal microbiota pancreatic islet -celldiabetesNutrition. Foods and food supplybusiness.industrydietary polyphenolsfood and beveragesdiabetic complicationclinical studyTP368-456Pharmacologymedicine.diseaseFood processing and manufactureGlucose absorptionBioavailabilityClinical studyglucose absorptionDiabetic complicationPolyphenolDiabetes mellitusmedicineTX341-641bioavailabilitybusinessAntidiabetic agentsFood Frontiers
researchProduct